Ocugen

Ocugen’s Strategic Pivot: A New Financial Leader for the Commercial Leap

kashif hafeez - February 11, 2026

Ocugen Bolsters Leadership with Gene Therapy Expert Ahead of Pivotal Year

kashif hafeez - February 10, 2026

Ocugen’s Pivotal Year: Key Clinical Milestones Set for 2026

Brett Shapiro - February 9, 2026

Ocugen’s Crucial Quarter: Clinical Data and Regulatory Milestones on the Horizon

angelina - February 6, 2026

Ocugen Shares Show Divergence Amid Technical Downgrade

angelina - January 3, 2026

Ocugen’s Strategic Pivot Sets Stage for Critical Year

December 30, 2025

Ocugen CEO’s Compensation Tied to Critical Regulatory Milestones

December 18, 2025

Ocugen Stock: A Study in Contrasts Between Technical Pressure and Lofty Analyst Targets

kashif hafeez - December 18, 2025

Ocugen Approaches Pivotal Juncture with Gene Therapy Pipeline

December 17, 2025

Ocugen Shares Face Mounting Technical and Regulatory Pressure

angelina - December 7, 2025

Ocugen Faces Mounting Financial Pressure as Cash Reserves Dwindle

November 13, 2025

Ocugen Shares Extend Decline Amid Mixed Financial Results

angelina - November 11, 2025

Ocugen’s Strategic Moves Position Biotech Firm for Critical Regulatory Phase

angelina - November 11, 2025

Ocugen’s Financial Crossroads: Balancing Innovation Against Mounting Pressures

November 10, 2025

Ocugen’s Financial Crossroads: Clinical Milestones Amid Mounting Losses

November 9, 2025

12 Page 1 of 2